Markus Schwaiger

Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction.

[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model.

Radionuclide and hybrid imaging of recurrent prostate cancer.

Registration of myocardial PET and SPECT for viability assessment using mutual information.

Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial.

Cardiovascular disease.

Magnetic resonance imaging of myocardial injury and ventricular torsion after marathon running.

Reference region-based pharmacokinetic modeling in quantitative dynamic contract-enhanced MRI allows robust treatment monitoring in a rat liver tumor model despite cardiovascular changes.

Comparison of different SUV-based methods for response prediction to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRI.

Phenotyping of tumor biology in patients by multimodality multiparametric imaging: relationship of microcirculation, alphavbeta3 expression, and glucose metabolism.

Effects of handedness (left vs right) and cannabis abuse on intermanual coordination and negative symptoms in schizophrenic patients of the paranoid type.

Semiautomatic algorithm for lymph node analysis corrected for partial volume effects in combined positron emission tomography-computed tomography.

PET imaging of αvβ3 expression in cancer patients.

Synthesis and evaluation of 11C-labeled imidazo[2,1-b]benzothiazoles (IBTs) as PET tracers for imaging β-amyloid plaques in Alzheimer's disease.

PET of αvbeta3-integrin and αvbeta5-integrin expression with 18F-fluciclatide for assessment of response to targeted therapy: ready for prime time?

Validation of preclinical multiparametric imaging for prediction of necrosis in hepatocellular carcinoma after embolization.

MRI of coronary wall remodeling in a swine model of coronary injury using an elastin-binding contrast agent.

Transmit gain calibration for nonproton MR using the Bloch-Siegert shift.

Simplified quantification of myocardial flow reserve with flurpiridaz F 18: validation with microspheres in a pig model.

The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration.

Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment.

Molecular imaging of proliferation and glucose utilization: utility for monitoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancer.

PET Imaging of Integrin αVβ3 Expression.

An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.

PET-MRI fusion in head-and-neck oncology: current status and implications for hybrid PET/MRI.

Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer.

The next generation of cardiac positron emission tomography imaging agents: discovery of flurpiridaz F-18 for detection of coronary disease.

Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions.

Functional Imaging of Pheochromocytoma with Ga-DOTATOC and C-HED in a Genetically Defined Rat Model of Multiple Endocrine Neoplasia.

(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.

Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumours?

Diagnostic value of standard and extended ECG leads for the detection of acute myocardial infarction as compared to contrast-enhanced magnetic resonance imaging.

Robust slice-selective broadband refocusing pulses.

PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent.

Long-term myocardial scarring after operation for anomalous left coronary artery from the pulmonary artery.

A pilot study to evaluate 3'-deoxy-3'-18F-fluorothymidine pet for initial and early response imaging in mantle cell lymphoma.

Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction.

Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner.

IDEAL spiral CSI for dynamic metabolic MR imaging of hyperpolarized [1-13C]pyruvate.

How many PET tracers do we need?

Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.

Does the amplatzer septal occluder device alter ventricular contraction pattern? A ventricular motion analysis by MR tagging.

Molecular imaging of early αvβ3 integrin expression predicts long-term left-ventricle remodeling after myocardial infarction in rats.

Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease.

68Ga-NODAGA-RGD is a suitable substitute for (18)F-Galacto-RGD and can be produced with high specific activity in a cGMP/GRP compliant automated process.

Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo.

Diet intervention reduces uptake of αvβ3 integrin-targeted PET tracer 18F-galacto-RGD in mouse atherosclerotic plaques.

First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.

Drug-based optical agents: infiltrating clinics at lower risk.

Three-dimensional imaging of the aortic vessel wall using an elastin-specific magnetic resonance contrast agent.

Saturation-recovery metabolic-exchange rate imaging with hyperpolarized [1-13C] pyruvate using spectral-spatial excitation.

Quantitative assessment of glucose metabolism in the vessel wall of abdominal aortic aneurysms: correlation with histology and role of partial volume correction.

FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy.

Workflow and scan protocol considerations for integrated whole-body PET/MRI in oncology.

A case of multimodality multiparametric 11C-choline PET/MR for biopsy targeting in prior biopsy-negative primary prostate cancer.

[18F]FLT is superior to [18F]FDG for predicting early response to antiproliferative treatment in high-grade lymphoma in a dose-dependent manner.

Simultaneous positron emission tomography/magnetic resonance imaging identifies sustained regional abnormalities in cardiac metabolism and function in stress-induced transient midventricular ballooning syndrome: a variant of Takotsubo cardiomyopathy.

(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.

Positron emission tomography in the assessment of left ventricular function in healthy rats: a comparison of four imaging methods.

Association of ST-elevation and non-ST-elevation presentation on ECG with transmurality and size of myocardial infarction as assessed by contrast-enhanced magnetic resonance imaging.

PET and SPECT in heart failure.

Evaluation of Feasibility and Image Quality of 68Ga-DOTATOC Positron Emission Tomography/Magnetic Resonance in Comparison With Positron Emission Tomography/Computed Tomography in Patients With Neuroendocrine Tumors.

Hybrid PET/MR imaging of the heart: potential, initial experiences, and future prospects.

Sensitivity of PET/MRI to detect recurrence of prostate cancer.

PET/MR: a paradigm shift.

(S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetry.

Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.

Comparison of cyclic RGD peptides for αvβ3 integrin detection in a rat model of myocardial infarction.

PET/MR in prostate cancer: technical aspects and potential diagnostic value.

Myeloablative anti-CD20 radioimmunotherapy +/- high-dose chemotherapy followed by autologous stem cell support for relapsed/refractory B-cell lymphoma results in excellent long-term survival.

Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer.

Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.

Biodistribution and radiation dosimetry in healthy volunteers of a novel tumour-specific probe for PET/CT imaging: BAY 85-8050.

Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.

Selective imaging of the angiogenic relevant integrins α5β1 and αvβ3.

Preclinical evaluation of 18F-LMI1195 for in vivo imaging of pheochromocytoma in the MENX tumor model.

EGFR-Targeted Adenovirus Dendrimer Coating for Improved Systemic Delivery of the Theranostic NIS Gene.

Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients.

Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.

Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.

PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis.

Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw?

Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis?

Self-gated radial MRI for respiratory motion compensation on hybrid PET/MR systems.

Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.

PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.

Textural Parameters of Tumor Heterogeneity in ¹⁸F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer.

Limited-projection-angle hybrid fluorescence molecular tomography of multiple molecules.

Effects of eye dominance (left vs. right) and cannabis use on intermanual coordination and negative symptoms in schizophrenia patients.

Introduction.

Multimodality multiparametric imaging of early tumor response to a novel antiangiogenic therapy based on anticalins.

PET/MR in Oncology: Non-18F-FDG Tracers for Routine Applications.

Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for ¹⁸F-FDG Brain Imaging in Patients Examined for Suspected Dementia.

Ventricular sympathetic innervation in patients with transposition of the great arteries after arterial switch operation and Rastelli procedure: impact of arterial dissection and coronary reimplantation.

Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT.

A Novel (18)F-Labeled Imidazo[2,1-b]benzothiazole (IBT) for High-Contrast PET Imaging of β-Amyloid Plaques.

Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphoma.

Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL.

Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy.

Quantified pH imaging with hyperpolarized (13) C-bicarbonate.

Positron emission tomography/magnetic resonance imaging with 68Gallium-labeled ligand of prostate-specific membrane antigen: promising novel option in prostate cancer imaging?

Treatment of acute left main occlusion by early revascularization combined with extracorporeal circulation achieves substantial myocardial salvage as assessed by simultaneous positron emission tomography/magnetic resonance imaging.

Comparison of [¹¹C]choline ([¹¹C]CHO) and S(+)-β-methyl-[¹¹C]choline ([¹¹C]SMC) as imaging probes for prostate cancer in a PC-3 prostate cancer xenograft model.

11C-Choline PET/pathology image coregistration in primary localized prostate cancer.

Detection of acute inflammatory myocarditis in Epstein Barr virus infection using hybrid 18F-fluoro-deoxyglucose-positron emission tomography/magnetic resonance imaging.

Novel approach of MALDI drug imaging, immunohistochemistry, and digital image analysis for drug distribution studies in tissues.

A 16-channel MR coil for simultaneous PET/MR imaging in breast cancer.

An integrated bioimpedance--ECG gating technique for respiratory and cardiac motion compensation in cardiac PET.

Metabolic imaging of hyperpolarized [1-(13) C]acetate and [1-(13) C]acetylcarnitine - investigation of the influence of dobutamine induced stress.

Diagnostic value of retrospective PET-MRI fusion in head-and-neck cancer.

(68)Ga-PSMA PET/MR with multimodality image analysis for primary prostate cancer.

Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.

High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation.

Multisite Kinetic Modeling of (13)C Metabolic MR Using [1-(13)C]Pyruvate.

Motion correction strategies for integrated PET/MR.

Evaluation of 18F-fluoride PET/MR and PET/CT in patients with foot pain of unclear cause.

PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake.

In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.

Myocardial blood flow in patients with transposition of the great arteries – risk factor for dysfunction of the morphologic systemic right ventricle late after atrial repair.

Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy.

Myocardial Kinetics of a Novel [(18)F]-Labeled Sympathetic Nerve PET Tracer LMI1195 in the Isolated Perfused Rabbit Heart.

Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging.

PET/MRI of the heart.

The lower hippocampus global connectivity, the higher its local metabolism in Alzheimer disease.

Imaging systemic inflammatory networks in ischemic heart disease.

Comparison of acquisition schemes for hyperpolarised ¹³C imaging.

FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice.

Twins in spirit - episode I: comparative preclinical evaluation of [(68)Ga]DOTATATE and [(68)Ga]HA-DOTATATE.

Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer.

Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib.

⁸⁹Zr-Labeled Versus ¹²⁴I-Labeled αHER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo.

Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors.

Comparison of 18F-Labeled Fluoroalkylphosphonium Cations with 13N-NH3 for PET Myocardial Perfusion Imaging.

68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.

Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer.

Retention Kinetics of the 18F-Labeled Sympathetic Nerve PET Tracer LMI1195: Comparison with 11C-Hydroxyephedrine and 123I-MIBG.

Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel Analysis.

Re: Lars Budäus, Sami-Ramzi Leyh-Bannurah, Georg Salomon, et al. Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy. Eur Urol 2016;69:393-6.

Discrimination Between Brown and White Adipose Tissue Using a 2-Point Dixon Water-Fat Separation Method in Simultaneous PET/MRI.

High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.

Parameterization of hyperpolarized (13)C-bicarbonate-dissolution dynamic nuclear polarization.

Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.

In vivo biokinetic and metabolic characterization of the ⁶⁸Ga-labelled α5β1-selective peptidomimetic FR366.

Intense PSMA-expression using (68)Ga-PSMA PET/CT in a paravertebral schwannoma mimicking prostate cancer metastasis.

68Ga-PSMA-HBED-CC PET for Differential Diagnosis of Suggestive Lung Lesions in Patients with Prostate Cancer.

Stable Peptides Instead of Stapled Peptides: Highly Potent αvβ6-Selective Integrin Ligands.

Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer.

Visualization of stress fractures of the foot using PET-MRI: a feasibility study.

First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers.

Characterization of Physiologic (18)F FSPG Uptake in Healthy Volunteers.

Simultaneous (68)Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer.

α-trideuteromethyl[15N]glutamine: A long-lived hyperpolarized perfusion marker.

68Ga Prostate-Specific Membrane Antigen Uptake in Renal Cell Cancer Lymph Node Metastases.

Current use of PSMA-PET in prostate cancer management.

Combined Positron Emission Tomography and Magnetic Resonance as Translational Tool in Cardiology.

Systemic Radioligand Therapy with (177)Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer.

Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.

Non-invasive assessment of inter-and intrapatient variability of integrin expression in metastasized prostate cancer by PET.

The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity.

Variation of Specific Activities of 68Ga-Aquibeprin and 68Ga-Avebetrin Enables Selective PET Imaging of Different Expression Levels of Integrins α5β1 and αvβ3.

Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia.

Multiparametric human hepatocellular carcinoma characterization and therapy response evaluation by hyperpolarized (13) C MRSI.

Biodistribution and radiation dosimetry of (68)Ga-PSMA HBED CC-a PSMA specific probe for PET imaging of prostate cancer.

Noninvasive In Vivo Imaging and Biologic Characterization of Thyroid Tumors by ImmunoPET Targeting of Galectin-3.

Integration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study.

Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.

Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in Patients With Early Recurrent Prostate Cancer.

(68)Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report.

Comparison of bone scintigraphy and (68)Ga-PSMA PET for skeletal staging in prostate cancer.

Prospective evaluation of [(11)C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer.

PSMA Theranostics Using PET and Subsequent Radioguided Surgery in Recurrent Prostate Cancer.

Probing lactate secretion in tumours with hyperpolarised NMR.

Immuno-PET Imaging of Engineered Human T Cells in Tumors.

Prolonged Elevated Cardiac Troponin After Marathon Running Is A Sign For Myocardial Damage: 2307 June 2, 5: 00 PM - 5: 15 PM.

A Continuously Infused Microfluidic Radioassay System for the Characterization of Cellular Pharmacokinetics.

Measurement of extracellular volume and transit time heterogeneity using contrast-enhanced myocardial perfusion MRI in patients after acute myocardial infarction.

Quantitative Analysis of [(18)F]FMISO PET for Tumor Hypoxia: Correlation of Modeling Results with Immunohistochemistry.

A comparison of quantitative methods for clinical imaging with hyperpolarized (13)C-pyruvate.

Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion.

Science translational medicine issue.

Following Metabolism in Living Microorganisms by Hyperpolarized (1)H NMR.

Observations With Simultaneous 18F-FDG PET and MR Imaging in Peripheral Artery Disease.

[11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy.

Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice.

A pilot trial of doxorubicin containing phosphatidyldiglycerol based thermosensitive liposomes in spontaneous feline soft tissue sarcoma.

Imaging approaches to optimize molecular therapies.

Preclinical evaluation and first patient application of 99mTc-PSMA-I&S for SPECT imaging and radioguided surgery in prostate cancer.

In Vivo Imaging of Tumor Metabolism and Acidosis by Combining PET and MRI-CEST pH Imaging.

Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo - a comparison to [(68)Ga]pentixafor.

PET/MR: Yet another Tesla?

Radiation dosimetry for 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer: Absorbed dose in normal organs and tumor lesions.

Co-clinical assessment of tumor cellularity in pancreatic cancer.

Data-driven identification of intensity normalization region based on longitudinal coherency of (18)F-FDG metabolism in the healthy brain.

Effect of blood activity on dosimetric calculations for radiopharmaceuticals.

Hyperpolarized Multi-Metal (13)C-Sensors for Magnetic Resonance Imaging.

Imaging the cytokine receptor CXCR4 in atherosclerotic plaques with the radiotracer 68Ga-pentixafor for positron emission tomography.

Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients' Attitude towards CAM in a University-Based Oncology Center in Germany.

Value of (111) In-prostate-specific membrane antigen (PSMA)-radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow-up.

Intra-lesional spatial correlation of static and dynamic FET-PET parameters with MRI-based cerebral blood volume in patients with untreated glioma.

Disease activity and vascular involvement in retroperitoneal fibrosis: first experience with fully integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging compared to clinical and laboratory parameters.